Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    04-October-2000      
Issue 174 Next Update - 14:00 UTC 08:00 EST    05-October-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Back To Vidyya Today In Vidyyasm

Vidyya Medical News Service For 04-October-2000:

The National Heart, Lung, and Blood Institute (NHLBI) has launched a major initiative to advance genomic research related to heart, lung, blood, and sleep health and disorders. On 30 September the NHLBI issued grants totaling $37 million to establish 11 Programs for Genomic Applications (PGAs). The purpose of the PGAs is to identify the human genes particularly relevant to heart, lung, blood, and sleep functions.

There was bad news for a big drug company yesterday. The Food and Drug Administration announced that Wyeth-Ayerst Laboratories Division of American Home Products Corporation and Wyeth-Ayerst Pharmaceuticals, Inc. (Wyeth) have signed a consent decree of permanent injunction in which Wyeth agreed to a series of measures aimed at ensuring that the products manufactured at Wyeth's Marietta, Pa. and Pearl River, N.Y. facilities are made in compliance with FDA's good manufacturing practice (GMP) regulations.

On a brighter note, today is National Walk To School Day. The CDC is sponsoring the event that encourages school age children to engage in physical activity. This issue of Vidyya contains a guide to help communities develop and implement a year-long walk-to-school initiative. The guide comes complete with: a step-by-step checklist, kids walk-to-school tools, safety tips on walking, biking, school bus safety, and stranger danger tips.

Dietary use of garlic may lower some types of cholesterol in the short term, but it does not appear to offer long-term protection against cardiovascular disease, says a new evidence report released by the Agency for Healthcare Research and Quality (AHRQ). Garlic may help to reduce low-density lipids (LDL), or "bad" cholesterol and triglycerides. However, the evidence is only for short-term (1 to 3 months) effects.

The evidence report is a systematic review that summarizes clinical studies of garlic in humans. It addresses three areas: the effects on cardiovascular-related disease and factors such as lipids, blood pressure, glucose, atherosclerosis, and thrombosis; any protective associations with cancer and any clinical adverse effects. A summary of the report appears in today's issue.

The articles in today's Vidyya are:

As always, we hope you enjoy the issue.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.